ArticleWorld journal of urology2022

Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients.

Takashi Ueda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.